Immutep Limited: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

Income statement

Metric	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Revenue	10m	8m	5m	7m
Selling, general and administrative	9m	9m	9m	7m
Pre-tax income	−61m	−43m	−40m	−32m
Income tax	0	0	0	34
Net income	−61m	−43m	−40m	−32m
Earnings per share	−0.04	−0.04	−0.04	−0.04
Earnings per share, diluted	−0.04	−0.04	−0.04	−0.04

Metric	Aug 18, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash and equivalents	—	67m	162m	123m	80m	61m
Receivables	—	10m	7m	8m	—

Metric	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Operating cash flow	−62m	−35m	−35m	−30m
Capital expenditure	45,769	29,215	82,735	22,914
Investing cash flow	−39m	−21m	−82,735	−22,914
Financing cash flow

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)